HSIE Institutional Report: Hyundai Motor India
By Prime Research | Published at: Feb 3, 2026 06:06 PM IST

New Plant Costs to Cap Margin Expansion
Hyundai Motor India’s (HMI) EBITDA margin at 11.2% missed our estimate by 126bps and Bloomberg consensus estimate by 152bps, mainly due to adverse gross margins and higher costs related to the new plant. Management has called out for higher costs related to the new plant, like labor, manufacturing overheads and depreciation, to sustain over the next 3-4 quarters. While we are positive on the PV industry over the medium term, led by the GST rate rationalization and exports potential, we remain concerned on the company’s lack of aggression in the Indian market with regards to volumes and market share, where competition is getting more aggressive. We value the company at 25x Dec-27 EPS for a target price of INR 2,282, and maintain a REDUCE rating.
Hyundai Motor India Quarterly performance
Revenue at INR 179.7bn grew 8% YoY and 2.9% QoQ, 1.8% above our estimate and in line with Bloomberg consensus estimate. Realization remained flat QoQ, despite unfavorable product mix, as discounts eased from 3.2% in Q2 to 2.6% in Q3. Gross margin deteriorated 124bps QoQ on the back of a unfavorable product mix, commodity inflation, and plant startup costs.
Call Takeaways
- Management indicated that based on a discussion within SIAM, broadly 6% YoY growth is expected for domestic passenger vehicles sales for FY27.
- It highlighted ASP improved 5% YoY on the back of a strong mix and prudent pricing, while ASP was maintained on a QoQ basis despite seasonality and higher competition.
- Discounts declined from 3.2% on ASP in Q2FY26 to 2.6% in Q3FY26.
- It indicated that a total impact of about 100bps on account on new plant-related costs is expected to continue for a year, of which an impact of 60-70bps has been borne in Q3FY26.
- Profitability was impacted on a YoY basis by the increase in processing cost linked with capacity expansion, while on a QoQ basis, it was due to unfavorable mix and marketing expenses.
- The launch of new taxi-oriented range along with GST rate cut has been helping ‘Aura’ sales volumes.
- With a shift of all-new Venue to the Pune facility, the Pune plant has already achieved 90% capacity utilization.
- Management indicated that the channel inventory is low, with inventory being 2-3 weeks as of 31 December 2025, which increased to four weeks by the end of January 2026 (normalized inventory in Jan is usually five weeks).
- Commodity price inflation continues to put stress on margins, though it is working on mitigating this through long-term supplier sourcing strategy, cost optimization, localization, and value engineering.
- The rural contribution to sales was more than 24% in Q3FY26, the highest-ever quarterly.
- It maintained its guidance on 11 14% EBITDA margin to continue for the coming years.
- As a % of domestic sales volume, CNG is now at 16% and diesel at 21%.
Hyundai Motor India Quarterly/Annual Financial Summary
| YE Mar (INR mn) | 3QFY26 | 3QFY25 | YoY (%) | 2QFY26 | QoQ (%) | FY25 | FY26E | FY27E | FY28E |
|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1,79,735 | 1,66,480 | 8.0 | 1,74,608 | 2.9 | 6,03,076 | 6,98,291 | 6,91,929 | 7,16,275 |
| EBITDA | 20,183 | 18,755 | 7.6 | 24,289 | (16.9) | 75,488 | 91,326 | 89,538 | 90,163 |
| EBITDA % | 11.2 | 11.3 | -4bps | 13.9 | -269bps | 12.5 | 13.1 | 12.9 | 12.6 |
| APAT | 12,344 | 11,607 | 6.3 | 15,723 | (21.5) | 47,050 | 60,604 | 56,602 | 56,685 |
| Diluted EPS (INR) | 15.2 | 14.3 | 9.3 | 19.3 | (21.5) | 58.0 | 74.6 | 69.4 | 69.8 |
| P/E (x) | 38.1 | 29.6 | 31.8 | 31.7 | |||||
| EV / EBITDA (x) | 21.6 | 18.7 | 19.2 | 19.2 | |||||
| RoE (%) | 25.5 | 39.5 | 41.8 | 31.3 |
Source: HSIE Research (HSIE Results Daily – 03 Feb 26 – HSIE-202602030656002630379.pdf)
Disclaimer:
This report has been prepared by HDFC Securities Ltd and is solely for information of the recipient only. The report must not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual investor; readers are requested to take professional advice before investing. This report may have been refined using AI tools to enhance clarity and readability.
Nothing in this document should be construed as investment advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in securities of the companies referred in this document (including merits and risks) and should consult their own advisors to determine merits and risks of such investment. The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guarantee, representation or warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. Descriptions of any company or companies or their securities mentioned herein are not intended to be complete. HSL is not obligated to update this report for such changes. HSL has the right to make changes and modifications at any time.
This report is not directed to, or intended for display, downloading, printing, reproduction or for distribution to use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction.
If this report is inadvertently or has reached any person in such country, especially, United States of America, the same should be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or published in whole or in part, directly or indirectly, for any purposes or in any manner.
Foreign currencies denominated securities, where mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security.
This document is not, and should not, be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report should not be construed as an invitation or solicitation to do business with HSL. HSL may from time to time solicit from, or perform brokerage, or other services for, any company mentioned in this mail and/or its attachments.
HSL and its affiliated company(ies), their directors and employees may: (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.
HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, for the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividends or income etc.
HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report. As regards the associates of HSL please refer the website.
HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months.
HSL or its associates might have received any compensation from the companies mentioned in the report during the preceding twelve months from the date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service or a merger or specific transaction in the normal course of business.
HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued other reports that are inconsistent and reach different conclusion from the information presented in this report.
Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report.
Please note that HDFC Securities has a proprietary trading desk. This desk maintains an arm’s length distance with the Research team and all its activities are segregated from Research activities. The proprietary desk operates independently, potentially leading to investment decisions that may deviate from research views.
HDFC Securities Limited, I Think Techno Campus, Building – b, “Alpha”, Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066
Compliance Officer: Mr Milan V Karker Email: complianceofficer@hdfcsec.com Phone: (022) 3045 3600
For grievance redressal contact Customer Care Team Email: customercare@hdfcsec.com Phone: (022) 3901 9400
HDFC Securities Limited. SEBI Reg. No.: INESE, BSE, MSEI, MCX: INZ000186537; AMFI Reg. No. ARN: 13549; PFRDA Reg. No. POP: 11092018; IRDA Corporate Agent License No.: CA0062; SEBI Research Analyst Reg. No.: INH000002475; SEBI Investment Adviser Reg. No.: INA000011538; CIN – U67120MH2000PLC152193 Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Mutual Funds Investments are subject to market risks. Please read the offer and scheme related documents carefully before investing.
Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

